Fig. 4From: Addition of chemoradiotherapy to palliative chemotherapy in de novo metastatic nasopharyngeal carcinoma: a real-world studyLandmark analysis of OS for propensity score-matched patients receiving PCT followed by CCRT or RT. A Patients survived for ≥ 1 year. B Patients survived for ≥ 2 years. OS overall survival; PCT palliative chemotherapy, CCRT concurrent chemoradiotherapy, RT radiotherapyBack to article page